Trusted Resources: People & Places
Online groups, photo galleries and blogs
Julie Eisengart, PhD, LP
Department of Pediatrics
University of Minnesota
100 Church Street SE
Minneapolis, Minnesota, United States
Dr. Julie Eisengart is an Associate Professor in the Department of Pediatrics and the Director of the Neurodevelopmental Program in Rare Disease. As a Pediatric Neuropsychologist, she specializes in rare neurodegenerative disorders of childhood as well as a range of complex medical conditions, and she works with patients from infancy to young adulthood. Her clinical interests include assessing the strengths and needs of children affected by complex medical diagnoses, throughout their medical journeys, to optimize whole-child, whole-family care and supports. As a clinical supervisor and mentor, she values her role in training future psychologists and supporting their development into independent, balanced professionals.
Dr. Eisengart’s research interests include lysosomal storage disorders like Mucopolysaccharidosis (MPS), natural histories and treatment outcomes of rare diseases involving the central nervous system. She focuses on the changing relationships between brain structure, biochemical abnormalities, and brain function in rare disease, with the goal of predicting outcomes and improving supportive planning. She has been heavily involved in examining outcomes of early diagnosis, newborn screening, and/or novel therapies for rare disease. Her research extends to defining and measuring aspects of disease that are under-represented in the clinical and research communities but are important and meaningful to patients and their families, such as neurobehavioral symptoms and the caregiver lived experience.
Difficulties Associated With Enzyme Replacement Therapy for MucopolysaccharidosesMucopolysaccharidoses are extremely rare...
Gene Therapy for Sanfilippo: Where We Are NowGene therapy is a promising approach for...
Developing a Treatment Plan for Sanfilippo SyndromeSanfilippo syndrome is a neurodegenerati...
The Beginning of the End of Allogeneic Transplantation for Hurler SyndromeHurler syndrome (mucopolysaccharidosis t...
Airway Management in Mucopolysaccharidosis: A Retrospective Case Series ReviewAirway management can be difficult in su...
Europe Grants Orphan Drug Status to JR-441, ERT for Sanfilippo AThe European Commission has granted an o...